Evaluation of cardiovascular events in patients with hepatocellular carcinoma treated with sorafenib in the clinical practice. The Cardio-sor study

dc.contributor.author	Carballo Folgoso, Lorena
dc.contributor.author	Ávarez Velasco, Rut
dc.contributor.author	Lorca Gutiérrez, Rebeca
dc.contributor.author	Castaño García, Andrés
dc.contributor.author	Cuevas, Javier
dc.contributor.author	Luisa González Diéguez, María Luisa
dc.contributor.author	Martin, Maria
dc.contributor.author	Álvarez Navascués, Carmen
dc.contributor.author	Cadahía Rodrigo, Valle
dc.contributor.author	Morís de la Tassa, César
dc.contributor.author	Rodríguez García, Manuel
dc.contributor.author	Varela Calvo, María
dc.date.accessioned	2021-11-18T12:25:11Z
dc.date.available	2021-11-18T12:25:11Z
dc.date.issued	2021
dc.identifier.citation	Liver International, 41(9), p. 2200-2211 (2021); doi:10.1111/liv.14941
dc.identifier.issn	1478-3223
dc.identifier.issn	1478-3231
dc.identifier.uri	http://hdl.handle.net/10651/61303
dc.format.extent	p. 2200-2211
dc.language.iso	eng
dc.relation.ispartof	Liver International
dc.rights	© 2021 The Authors. Liver International published by John Wiley & Sons Ltd.
dc.rights	CC Reconocimiento - No Comercial - Sin Obra Derivada 4.0 Internacional
dc.rights.uri	http://creativecommons.org/licenses/by-nc-nd/4.0/
dc.source	WOS:000654219100001
dc.title	Evaluation of cardiovascular events in patients with hepatocellular carcinoma treated with sorafenib in the clinical practice. The Cardio-sor study
dc.type	journal article
dc.identifier.doi	10.1111/liv.14941
dc.relation.publisherversion	http://dx.doi.org/10.1111/liv.14941
dc.rights.accessRights	open access
dc.type.hasVersion	VoR

Este ítem está sujeto a una licencia Creative Commons